Prof. Dr. Çağatay Çağlar
Professor of Ophthalmology · FEBO-certified · more than 20 years in retina, macula and vitreoretinal surgery.
Retina
Stem Cell Therapy for Retinal Diseases
Discuss whether further retinal assessment may be appropriate for your situation.
What this is
This service page provides a structure for cautious conversations about retinal disease. It is designed to support assessment and information sharing, not to promise a cure or a particular outcome.
What we perform
These are the routes we perform under this heading, and what separates them.
- Retinitis pigmentosaA retinal assessment pathway for people seeking information about supportive or experimental approaches.Starts from a documented diagnosis and asks what further assessment is appropriate.
- Macular degenerationA cautious discussion pathway for retinal findings and potential supportive or experimental options.Reviews stage and current management before any supportive option is discussed.
Which one applies to you is what the examination decides.
The treatments we perform
Open any one to read how it is carried out, the situations it suits, and what the visit involves.
Retinitis pigmentosa
A retinal assessment pathway for people seeking information about supportive or experimental approaches.
Retinitis pigmentosa has many causes and progression patterns. Any discussion of supportive or experimental approaches begins with a careful review of diagnosis, records and current eye health.
This page does not claim a cure or predict outcomes. The clinical team can explain what further assessment may involve and whether a particular pathway is appropriate to discuss.
Situations this suits
Someone with a documented retinal diagnosis seeking an assessment discussion.
Discussion begins with a careful review of diagnosis, records and current eye health.
Someone able to provide current eye records.
Available imaging, reports and medical history are reviewed before travel planning.
Someone who understands that suitability must be assessed individually.
The clinical team explains what further assessment may involve and whether a particular pathway is appropriate to discuss.
Situations this does not suit
Anyone seeking a guaranteed recovery of vision.
This page does not claim a cure or predict outcomes.
Someone without sufficient diagnostic information for review.
Diagnosis, records and current eye health are reviewed before supportive or experimental approaches are discussed.
Someone for whom the clinician identifies a different care priority.
Assessment may identify that another care route is more appropriate.
How the visit runs
- Before travel
Record review
Available imaging, reports and medical history are reviewed before travel planning.
- Day 1
In-person assessment
Retinal examination and testing help clarify the clinical picture.
- Day 1
Options discussion
The clinician explains appropriate supportive or experimental framing and any limits of available evidence.
- Follow-up
Follow-up plan
A follow-up approach is discussed based on the agreed clinical pathway.
While you heal
Assessment may identify that another care route is more appropriate. Treatment decisions require informed discussion of uncertainty and limitations.
Follow-up is planned around the individual clinical situation and the information available after you return home.
Where this happens
Questions people ask
Does this treatment cure retinitis pigmentosa?
No cure claim is made. The team first assesses whether any supportive or experimental discussion is clinically appropriate.
What records should I share?
Recent retinal imaging, reports and relevant medical history can help the team decide what further assessment may be needed.
Macular degeneration
A cautious discussion pathway for retinal findings and potential supportive or experimental options.
Macular degeneration requires individual assessment because diagnosis, stage and related health factors differ. Existing treatments and follow-up needs should be reviewed with the appropriate clinician.
Any consideration of supportive or experimental approaches is framed cautiously. It is not presented as a cure or a replacement for appropriate ongoing retinal care.
Situations this suits
Someone with documented macular findings seeking an assessment discussion.
Diagnosis, stage and related health factors require individual assessment.
Someone who can provide current imaging and reports.
The team reviews available imaging, diagnosis details and current management.
Someone prepared for a careful review of evidence and limitations.
Supportive or experimental approaches are framed cautiously and not presented as a cure.
Situations this does not suit
Anyone seeking a promised visual improvement.
Supportive or experimental approaches are not presented as a cure or a predicted outcome.
- Needs individual review
Someone whose records indicate urgent local care is needed.
Existing treatments and follow-up needs should be reviewed with the appropriate clinician.
Someone without a completed retinal assessment.
An in-person evaluation clarifies findings and what questions can be discussed.
How the visit runs
- Before travel
Information review
The team reviews available imaging, diagnosis details and current management.
- Day 1
Retinal examination
An in-person evaluation clarifies findings and what questions can be discussed.
- Day 1
Clinical conversation
Supportive or experimental framing, evidence limits and alternatives are discussed carefully.
- Continuing care
Continuing care
The follow-up plan considers ongoing care with your home eye specialist.
While you heal
Retinal conditions require individual clinical judgement. The team will explain uncertainties and what information is needed for a responsible discussion.
Maintain appropriate care with your home eye specialist and share the agreed follow-up information.
Where this happens
Questions people ask
Can this replace my current retinal treatment?
No. Your existing care should be discussed with your treating clinician, and any additional pathway requires individual assessment.
Why are outcomes not shown visually?
Retinal disease varies substantially. A visual comparison could imply a predictable result that is not appropriate.
Your specialist